Ductal invasive G2 and G3 carcinomas of the breast are the end stages of at least two different lines of genetic evolution-Reference-Cited by-同舟云学术

Ductal invasive G2 and G3 carcinomas of the breast are the end stages of at least two different lines of genetic evolution

Published:2001 Issue:2 Volume:194 Page:165-170
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:J. Pathol.

Author:

Buerger Horst,Mommers Ellen C.,Littmann Ruth,Simon Ronald,Diallo Raihanatou,Poremba Christopher,Dockhorn-Dworniczak Barbara,van Diest Paul J.,Boecker Werner

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Reference31 articles.

1. Genetic analysis of 53 lymph node-negative breast carcinomas by CGH and relation to clinical, pathological, morphometric, and DNA cytometric prognostic factors

2. Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes

3. Genetic alterations on chromosome 16 and 17 are important features of ductal carcinoma in situ of the breast and are associated with histologic type

4. Comparative genomic hybridization of ductal carcinomain situ of the breast?evidence of multiple genetic pathways

Cited by 132 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breast cancer vaccines: New insights into immunomodulatory and nano-therapeutic approaches;Journal of Controlled Release;2022-09

2. A qualitative transcriptional signature to reclassify histological grade of ER-positive breast cancer patients;BMC Genomics;2020-04-06

3. Atypical Mesonephric Hyperplasia of the Uterus Harbors Pathogenic Mutation of Kirsten Rat Sarcoma 2 Viral Oncogene Homolog (KRAS) and Gain of Chromosome 1q;Cancer Genomics - Proteomics;2020

4. Intraductal Proliferative Disease of the Breast;Practical Breast Pathology;2019

5. PRDM14: A Potential Target for Cancer Therapy;Current Cancer Drug Targets;2018-11-13